A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities

Alexey V. Danilov, Lionel D. Lewis, Frederick Lansigan, Liya Roudaia, Darcie L. Findley, Susan Y. Jones, Brian Highhouse, Bernard B. Beaulieu, Jennifer R. Brown

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities'. Together they form a unique fingerprint.